NEORPHYS has a total of 11 patent applications. Its first patent ever was published in 2006. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are PHARMAXIS PTY LTD, ALIHODZIC SULEJMAN and LEWIS AND CLARK PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 2 | |
#2 | Australia | 1 | |
#3 | Canada | 1 | |
#4 | China | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | France | 1 | |
#7 | Hong Kong | 1 | |
#8 | Israel | 1 | |
#9 | Republic of Korea | 1 | |
#10 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Sugars | |
#3 | Medical preparations | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Lahana Roger | 9 |
#2 | Larbouret Karine | 8 |
#3 | Castex Cedric | 8 |
#4 | Cedric Castex | 1 |
#5 | Roger Lahana | 1 |
#6 | Karine Larbouret | 1 |
#7 | Gros Christel | 1 |
Publication | Filing date | Title |
---|---|---|
WO2008142319A2 | Peptide analogues of melanocortin receptors | |
FR2907121A1 | NEW MORPHINIC DERIVATIVES |